Google Research tried to answer the question of how to design agent systems for optimal performance by running a controlled ...

Marc Santos is a Guides Staff Writer from the Philippines with a BA in Communication Arts and over six years of experience in writing gaming news and guides. He plays just about everything, from ...

This morning, the news broke that Larian Studios, developer of Baldur's Gate 3 and the upcoming, just-announced Divinity, is apparently using generative AI behind the scenes for things like concept ...

Baldur's Gate 3 and Divinity Original Sin developer Larian Studios generated a ton of hype (and no shortage of revulsion) when it revealed its next big role-playing game, Divinity, at The Game Awards ...

Games As other devs commit to AI as a development tool, Ubisoft is doubling down on "player-facing generative AI" Games "We do not police how developers make their games": Epic Games Store boss says ...

Respiratory viruses that have diverse strains and mutate rapidly, such as influenza and COVID-19, are difficult to block perfectly with vaccines alone. To solve this problem, KAIST's research team has ...

Necrobotics is a field of engineering that builds robots out of a mix of synthetic materials and animal body parts. It has produced micro-grippers with pneumatically operated legs taken from dead ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Cory Benfield discusses the evolution of ...

Stack Exchange Inc., the company behind the leading developer resource Stack Overflow, today announced the public launch of its new AI Assist feature. The company says it provides users with access to ...

Third Arc Bio is paying $5 million upfront to use Adagene’s tech in hopes of creating two new masked T-cell engagers. Down the line, Adagene could make up to $840 million in development and commercial ...

Novartis is taking another shot at alpha-synuclein as a target for treating Parkinson’s disease via a $200 million upfront licensing deal with Arrowhead Pharmaceuticals. The Swiss pharma plans to use ...

Lindsey Ellefson is Lifehacker’s Features Editor. She currently covers study and productivity hacks, as well as household and digital decluttering, and oversees the freelancers on the sex and ...